| NLS | Names Learning Test; Neu-Laxova syndrome; nonlinear least squares; normal lymphocyte supernatant |
|---|---|
| Tab | Tabella; Tablet; Á¤Á¦ |
| TAB | total autonomic blockage; typhoid, paratyphoid A, and paratyphoid B [vaccine] |
| TAb | therapeutic abortion |
| tab | tablet |
| TAB | Total androgen blockade |
|---|---|
| NLS | Nuclear Localization Signal |
| NLS | Nuclear localization sequence |
| TAB vaccine | A suspension of killed typhoid and paratyphoid A and B bacilli. See: typhoid vaccine. Synonym: TAB vaccine. (05 Mar 2000) |
|---|---|
| famotidine | <chemical> 3-(((2-((aminoiminomethyl)amino)-4-thiazolyl)methyl)thio)-n-(aminosulfonyl)propanimidamide. A competitive histamine h2-receptor antagonist. Its main pharmacodynamic effect is the inhibition of gastric secretion. The drug does not affect cardiovascular, renal, endocrine, pancreatic exocrine, or gastrointestinal motility functions. No clinically important interactions with other drugs have been described. It is an effective agent in the therapy of duodenal, gastric, and peptic ulcer, as well as of zollinger-ellison syndrome. Pharmacological action: anti-ulcer agents, histamine h2 antagonists. Chemical name: Propanimidamide, 3-(((2-((aminoiminomethyl)amino)-4-thiazolyl)methyl)thio)-N-(aminosulfonyl)- (12 Dec 1998) |
Á¦Ç°¸í |
ÆÇ¸Å»ç |
º¸ÇèÄÚµå | ¼ººÐ/ÇÔ·® | ±¸ºÐ/º¸Çè±Þ¿© |
|---|---|---|---|---|
|
³Ú½¼ÆÄ¸ðƼµòÁ¤40mg - »õâ
|
Çѱ¹³Ú½¼Á¦¾à |
A18400121 | Famotidine | Àü¹®ÀǾàǰ | »èÁ¦ |
|
³Ú½¼ÆÄ¸ðƼµòÁ¤20mg - »õâ
|
Çѱ¹³Ú½¼Á¦¾à |
A18450111 | Famotidine | Àü¹®ÀǾàǰ | ±Þ¿© |
|
³Ú½¼ÆÄ¸ðƼµòÁ¤10mg - »õâ
|
Çѱ¹³Ú½¼Á¦¾à |
A18450291 | Famotidine | Àü¹®ÀǾàǰ | »èÁ¦ |
Á¦Ç°¸í |
ÆÇ¸Å»ç |
º¸ÇèÄÚµå | ¼ººÐ/ÇÔ·® | ±¸ºÐ/º¸Çè±Þ¿© |
|---|